Kymera Therapeutics, Inc. (KYMR) Presents At Citi's 2025 Biopharma Back To School Conference Transcript

Core Insights - The session features Kymera Therapeutics with CEO Nello Mainolfi and CMO Jared Gollob presenting [1] Group 1 - The event is part of the Citi Biopharma Back to School Conference [1] - Geoffrey Meacham serves as the managing director and senior biopharma analyst [1] - The presentation includes members from the Kymera Therapeutics team, indicating a collaborative approach [1]